PMID: 11905636Mar 22, 2002Paper

STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia

The Lancet Oncology
M E O'Dwyer, B J Druker

Abstract

The deregulated tyrosine kinase activity of the BCR-ABL fusion protein has been established as the causative molecular event in chronic myelogenous leukaemia. Thus, the BCR-ABL tyrosine kinase is an ideal target for pharmacological inhibition. STI571 (formerly CGP57148B), is an ABL-specific inhibitor of tyrosine kinase that, in preclinical studies, selectively killed BCR-ABL-containing cells in vitro and in vivo. Clinical studies have shown the potential of this specifically targeted therapy, and STI571 is emerging as an important new therapeutic agent for chronic myelogenous leukaemia.

References

Mar 15, 1990·Nature·N HeisterkampJ Groffen
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·O N WitteD Baltimore
Apr 2, 1998·Hematology/oncology Clinics of North America·C M Verfaillie
Jan 29, 1999·Journal of the National Cancer Institute·P le CoutreC Gambacorti-Passerini
Apr 29, 1999·The New England Journal of Medicine·C L Sawyers
Jul 15, 1999·The New England Journal of Medicine·S FaderlH M Kantarjian
Sep 4, 1999·The New England Journal of Medicine·I Nash
Jan 5, 2000·The Journal of Clinical Investigation·B J Druker, N B Lydon

❮ Previous
Next ❯

Citations

Jan 28, 2003·Drug Discovery Today·Jeffrey S Ross, Geoffrey S Ginsburg
Jun 15, 2007·Journal of the National Cancer Institute·Seung Hyun OhHo-Young Lee
Jun 11, 2011·Biomarkers in Medicine·Jeffrey S Ross
Nov 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Monika A DavareBrian J Druker
Aug 2, 2001·Seminars in Pediatric Surgery·A M Davidoff, D A Hill
Sep 19, 2003·Wiener klinische Wochenschrift·Christian SillaberPeter Valent
Jan 17, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Brian J Druker
Jun 5, 2003·Seminars in Hematology·Andreas Hochhaus
Jun 5, 2003·Seminars in Hematology·Alex J Tipping, Junia V Melo
Apr 23, 2004·Trends in Molecular Medicine·Emanuel F Petricoin, Lance A Liotta
May 11, 2002·Stem Cells·Athena CountouriotisKathleen M Sakamoto
Aug 23, 2002·Pharmacology & Therapeutics·Keykavous Parang, Philip A Cole
Jul 4, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Yu-Chuen HuangYu-Jen Chen
Oct 2, 2007·Current Problems in Cancer·Russell P Kruzelock, William Short
Jun 15, 2011·Chemical Biology & Drug Design·Zachary B MackeyJames H McKerrow
Nov 23, 2005·Expert Opinion on Therapeutic Targets·Angela D Hamblin, Terry J Hamblin
May 17, 2005·Cancer Cell·Janet PlesciaDario C Altieri
Apr 2, 2014·Drug Discovery Today·Ariel Fernández
Jul 1, 2006·Expert Review of Clinical Immunology·Sebastian WittnebelAnne Caignard
Sep 1, 2009·Expert Opinion on Medical Diagnostics·Jeffrey S Ross
Dec 6, 2002·Expert Review of Molecular Diagnostics·Jeffrey S Ross, Geoffrey S Ginsburg
Apr 20, 2004·Journal of Cellular Physiology·K PulfordF Turturro
Sep 21, 2004·Oncogene·Craig T Jordan, Monica L Guzman
Feb 22, 2005·Journal of Cellular Biochemistry·Janet M D Plate, Jules E Harris
Jun 29, 2004·Advances in Anatomic Pathology·Jeffrey S RossGabriel N Hortobagyi
Aug 4, 2019·Cancers·Peppino MirabelliMarco Salvatore
Jan 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christelle CeboAnne Caignard
Jun 6, 2009·Journal of Cellular Biochemistry·Dario C AltieriGary S Stein
Jan 11, 2003·American Journal of Clinical Pathology·Jeffrey S Ross, Geoffrey S Ginsburg
Sep 5, 2006·Archives of Pathology & Laboratory Medicine·George J Netto, Rana Domiati Saad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.